sb 200646 has been researched along with ritanserin in 1 studies
Studies (sb 200646) | Trials (sb 200646) | Recent Studies (post-2010) (sb 200646) | Studies (ritanserin) | Trials (ritanserin) | Recent Studies (post-2010) (ritanserin) |
---|---|---|---|---|---|
24 | 0 | 5 | 735 | 75 | 71 |
Protein | Taxonomy | sb 200646 (IC50) | ritanserin (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0012 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.001 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
Diacylglycerol kinase alpha | Homo sapiens (human) | 9 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0025 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0025 | |
5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0012 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0025 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.012 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, S; Harding, WW; Kapadia, N | 1 |
1 other study(ies) available for sb 200646 and ritanserin
Article | Year |
---|---|
New halogenated tris-(phenylalkyl)amines as h5-HT2B receptor ligands.
Topics: Amines; Dose-Response Relationship, Drug; Humans; Ligands; Molecular Structure; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Structure-Activity Relationship | 2016 |